Black Diamond Therapeutics Company
Black Diamond Therapeutics is a precision oncology medicine company pioneering the discovery and development of small molecule.
Industry:
End-to-end Drug Development
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
2017-01-01
Employees Number:
1-10
Funding Status:
IPO
Investors Number:
16
Total Funding:
197100000
Estimated Revenue:
$10M to $50M
Last Funding Date:
2019-12-05
Last Funding Type:
Series C
Register and Claim Ownership